212 related articles for article (PubMed ID: 31209775)
1. Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders.
Nedelcovych MT; Kim BH; Zhu X; Lovell LE; Manning AA; Kelschenbach J; Hadas E; Chao W; Prchalová E; Dash RP; Wu Y; Alt J; Thomas AG; Rais R; Kamiya A; Volsky DJ; Slusher BS
J Neuroimmune Pharmacol; 2019 Sep; 14(3):391-400. PubMed ID: 31209775
[TBL] [Abstract][Full Text] [Related]
2. Glutamine antagonist JHU083 improves psychosocial behavior and sleep deficits in EcoHIV-infected mice.
Bell BJ; Hollinger KR; Deme P; Sakamoto S; Hasegawa Y; Volsky D; Kamiya A; Haughey N; Zhu X; Slusher BS
Brain Behav Immun Health; 2022 Aug; 23():100478. PubMed ID: 35734753
[TBL] [Abstract][Full Text] [Related]
3. N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders.
Nedelcovych MT; Tenora L; Kim BH; Kelschenbach J; Chao W; Hadas E; Jančařík A; Prchalová E; Zimmermann SC; Dash RP; Gadiano AJ; Garrett C; Furtmüller G; Oh B; Brandacher G; Alt J; Majer P; Volsky DJ; Rais R; Slusher BS
J Med Chem; 2017 Aug; 60(16):7186-7198. PubMed ID: 28759224
[TBL] [Abstract][Full Text] [Related]
4. Glutamine Antagonist JHU-083 Normalizes Aberrant Hippocampal Glutaminase Activity and Improves Cognition in APOE4 Mice.
Hollinger KR; Zhu X; Khoury ES; Thomas AG; Liaw K; Tallon C; Wu Y; Prchalova E; Kamiya A; Rojas C; Kannan S; Slusher BS
J Alzheimers Dis; 2020; 77(1):437-447. PubMed ID: 32675407
[TBL] [Abstract][Full Text] [Related]
5. Correction to: Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders.
Nedelcovych MT; Kim BH; Zhu X; Lovell LE; Manning AA; Kelschenbach J; Hadas E; Chao W; Prchalová E; Dash RP; Wu Y; Alt J; Thomas AG; Rais R; Kamiya A; Volsky DJ; Slusher BS
J Neuroimmune Pharmacol; 2021 Sep; 16(3):693. PubMed ID: 33914277
[No Abstract] [Full Text] [Related]
6. Small molecule glutaminase inhibitors block glutamate release from stimulated microglia.
Thomas AG; O'Driscoll CM; Bressler J; Kaufmann W; Rojas CJ; Slusher BS
Biochem Biophys Res Commun; 2014 Jan; 443(1):32-6. PubMed ID: 24269238
[TBL] [Abstract][Full Text] [Related]
7. Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome.
Khoury ES; Sharma A; Ramireddy RR; Thomas AG; Alt J; Fowler A; Rais R; Tsukamoto T; Blue ME; Slusher B; Kannan S; Kannan RM
Theranostics; 2020; 10(13):5736-5748. PubMed ID: 32483415
[No Abstract] [Full Text] [Related]
8. Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis.
Manivannan S; Baxter VK; Schultz KL; Slusher BS; Griffin DE
J Virol; 2016 Oct; 90(20):9251-62. PubMed ID: 27489275
[TBL] [Abstract][Full Text] [Related]
9. Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis.
Pham K; Maxwell MJ; Sweeney H; Alt J; Rais R; Eberhart CG; Slusher BS; Raabe EH
J Neuropathol Exp Neurol; 2021 Mar; 80(4):336-344. PubMed ID: 33712838
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of genetic toxicity of 6-diazo-5-oxo-l-norleucine (DON).
Kulkarni RM; Dakoulas EW; Miller KE; Terse PS
Toxicol Mech Methods; 2017 Sep; 27(7):518-527. PubMed ID: 28552037
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma.
Rais R; Jančařík A; Tenora L; Nedelcovych M; Alt J; Englert J; Rojas C; Le A; Elgogary A; Tan J; Monincová L; Pate K; Adams R; Ferraris D; Powell J; Majer P; Slusher BS
J Med Chem; 2016 Sep; 59(18):8621-33. PubMed ID: 27560860
[TBL] [Abstract][Full Text] [Related]
12. Neurological sequelae induced by alphavirus infection of the CNS are attenuated by treatment with the glutamine antagonist 6-diazo-5-oxo-l-norleucine.
Potter MC; Baxter VK; Mathey RW; Alt J; Rojas C; Griffin DE; Slusher BS
J Neurovirol; 2015 Apr; 21(2):159-73. PubMed ID: 25645378
[TBL] [Abstract][Full Text] [Related]
13. Targeting Glutamine Metabolism Ameliorates Autoimmune Hepatitis
Yu Q; Tu H; Yin X; Peng C; Dou C; Yang W; Wu W; Guan X; Li J; Yan H; Zang Y; Jiang H; Xia Q
Front Immunol; 2022; 13():880262. PubMed ID: 35663990
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages: linkage to HIV-1 associated dementia.
Zhao J; Lopez AL; Erichsen D; Herek S; Cotter RL; Curthoys NP; Zheng J
J Neurochem; 2004 Jan; 88(1):169-80. PubMed ID: 14675161
[TBL] [Abstract][Full Text] [Related]
15. Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l-norleucine (DON) containing a diazo precursor.
Gao RD; Hin N; Prchalová E; Pal A; Lam J; Rais R; Slusher BS; Tsukamoto T
Bioorg Med Chem Lett; 2021 Oct; 50():128321. PubMed ID: 34400301
[TBL] [Abstract][Full Text] [Related]
16. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment.
Gu CJ; Borjabad A; Hadas E; Kelschenbach J; Kim BH; Chao W; Arancio O; Suh J; Polsky B; McMillan J; Edagwa B; Gendelman HE; Potash MJ; Volsky DJ
PLoS Pathog; 2018 Jun; 14(6):e1007061. PubMed ID: 29879225
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the Analgesic Effect of the GLS Inhibitor 6-Diazo-5-Oxo-L-Norleucine in Vivo.
Crosby HA; Miller KE
Pharm Pharmacol Int J; 2016; 3(3):. PubMed ID: 29888760
[TBL] [Abstract][Full Text] [Related]
18. A redox-responsive prodrug for tumor-targeted glutamine restriction.
Prange CJ; Sayed NYB; Feng B; Goepfert C; Trujillo DO; Hu X; Tang L
J Control Release; 2024 Apr; 368():251-264. PubMed ID: 38403173
[TBL] [Abstract][Full Text] [Related]
19. We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of
Lemberg KM; Vornov JJ; Rais R; Slusher BS
Mol Cancer Ther; 2018 Sep; 17(9):1824-1832. PubMed ID: 30181331
[TBL] [Abstract][Full Text] [Related]
20. JHU-083 selectively blocks glutaminase activity in brain CD11b
Zhu X; Nedelcovych MT; Thomas AG; Hasegawa Y; Moreno-Megui A; Coomer W; Vohra V; Saito A; Perez G; Wu Y; Alt J; Prchalova E; Tenora L; Majer P; Rais R; Rojas C; Slusher BS; Kamiya A
Neuropsychopharmacology; 2019 Mar; 44(4):683-694. PubMed ID: 30127344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
